Your browser doesn't support javascript.
loading
The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
Conley, Barbara A; Staudt, Lou; Takebe, Naoko; Wheeler, David A; Wang, Linghua; Cardenas, Maria F; Korchina, Viktoriya; Zenklusen, Jean Claude; McShane, Lisa M; Tricoli, James V; Williams, Paul M; Lubensky, Irina; O'Sullivan-Coyne, Geraldine; Kohn, Elise; Little, Richard F; White, Jeffrey; Malik, Shakun; Harris, Lyndsay N; Mann, Bhupinder; Weil, Carol; Tarnuzzer, Roy; Karlovich, Chris; Rodgers, Brian; Shankar, Lalitha; Jacobs, Paula M; Nolan, Tracy; Berryman, Sean M; Gastier-Foster, Julie; Bowen, Jay; Leraas, Kristen; Shen, Hui; Laird, Peter W; Esteller, Manel; Miller, Vincent; Johnson, Adrienne; Edmondson, Elijah F; Giordano, Thomas J; Kim, Benjamin; Ivy, S Percy.
Affiliation
  • Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Staudt L; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.
  • Takebe N; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA.
  • Wheeler DA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
  • Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cardenas MF; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
  • Korchina V; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
  • Zenklusen JC; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.
  • McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Lubensky I; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • O'Sullivan-Coyne G; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA.
  • Kohn E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • White J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Malik S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Mann B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Tarnuzzer R; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.
  • Karlovich C; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Rodgers B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Shankar L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Jacobs PM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Nolan T; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Berryman SM; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Gastier-Foster J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA.
  • Bowen J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA.
  • Leraas K; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA.
  • Shen H; Van Andel Research Institute, Grand Rapids, MI, USA.
  • Laird PW; Van Andel Research Institute, Grand Rapids, MI, USA.
  • Esteller M; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, Spain.
  • Miller V; Foundation Medicine Inc, Cambridge, MA, USA.
  • Johnson A; Foundation Medicine Inc, Cambridge, MA, USA.
  • Edmondson EF; Pathology and Histology Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Giordano TJ; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Kim B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
J Natl Cancer Inst ; 113(1): 27-37, 2021 01 04.
Article in En | MEDLINE | ID: mdl-32339229
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcriptome / Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Natl Cancer Inst Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcriptome / Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Natl Cancer Inst Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States